An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes

Statistics in Medicine

Volumn 26, Issue 1, 2007, Pages 78-97

  Riley, R D ^a   Abrams, K R ^a   Lambert, P C ^a   Sutton, A J ^a   Thompson, J R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Meta regression; Missing data; Multiple outcomes; Multivariate meta analysis; Prognostic marker

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BIVARIATE ANALYSIS; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; RANDOMIZATION; STANDARDIZATION; SYSTEMATIC REVIEW; UNIVARIATE ANALYSIS;

ANALYSIS OF VARIANCE; BIOMETRY; DATA INTERPRETATION, STATISTICAL; DISEASE-FREE SURVIVAL; HUMANS; META-ANALYSIS; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS;

EID: 33846216340     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2524     Document Type: Article

References (43)

1. Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ Publishing Group: London, 2001.
2. Riley RD, Heney D, Jones DR et al. A systematic review of molecular and biological tumor markers in neuroblastoma. Clinical Cancer Research 2004; 10:4-12.
3. Gleser L, Olkin I. Stochastically dependent effect sizes. In The Handbook of Research Synthesis, Cooper H, Hedges L (eds). Russell Sage Foundation: New York, 1994; 339-355.
4. Berkey CS, Hoaglin DC, Antczak-Bouckoms A, Mosteller F, Colditz GA. Meta-analysis of multiple outcomes by regression with random effects. Statistics in Medicine 1998; 17:2537-2550.
5. Glas AS, Roos D, Deutekom M, Zwinderman AH, Bossuyt PM, Kurth KH. Tumor markers in the diagnosis of primary bladder cancer. A systematic review. Journal of Urology 2003; 169:1975-1982.
6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7:177-188.
7. Peto R. Why do we need systematic overviews of randomized trials? Statistics in Medicine 1987; 6:233-244.
8. Riley RD, Abrams KR, Sutton AJ et al. Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. British Journal of Cancer 2003; 88:1191-1198.
9. Thompson SG. Why and how sources of heterogeneity should be investigated? In Systematic Reviews in Health Care: Meta-Analysis in Context, Egger M, Davey Smith G, Altman DG (eds). BMJ Publishing Group: London, 2001; 157-175.
10. Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Statistics in Medicine 1996; 15:619-629.
11. Van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Statistics in Medicine 2002; 21:589-624.
12. Goldstein H. Restricted unbiased iterative generalized least-squares estimation. Biometrika 1989; 76:622-623.
13. Whitehead A. Meta-Analysis of Controlled Clinical Trials. Wiley: West Sussex, 2002.
14. Goldstein H. Multilevel Statistical Models. Edward Arnold: London, 1995.
15. Riley RD. Evidence synthesis of prognostic marker studies. Ph.D. Thesis, University of Leicester, 2005.
16. Zellner A. An efficient method for estimating seemingly unrelated regressions and tests of aggregation bias. Journal of the American Statistical Association 1962; 57:500-509.
17. Mehta JS, Swamy PAVB. Further evidence on the relative efficiences of Zellner's seemingly unrelated regressions estimator. Journal of the American Statistical Association 1976; 71:634-639.
18. Willan AR, Briggs AH, Hoch JS. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Economics 2004; 13:461-475.
19. Sohn SY. Multivariate meta-analysis with potentially correlated marketing study results. Naval Research Logistics 2000; 47:500-510.
20. Nam IS, Mengersen K, Garthwaite P. Multivariate meta-analysis. Statistics in Medicine 2003; 22:2309-2333.
21. Brown H, Prescott R. Applied Mixed Models in Medicine. Wiley: Chichester, 1999.
22. Little JA, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 2002.
23. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. British Medical Journal 2001; 323:101-105.
24. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56:455-463.
25. Riley RD, Sutton AJ, Abrams KR, Lambert PC. Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. Journal of Clinical Epidemiology 2004; 57(9):911-924.
26. Dear KB. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 1994; 50:989-1002.
27. Berrington A, Cox DR. Generalized least squares for the synthesis of correlated information. Biostatistics 2003; 4:423-431.
28. Arends LR, Voko Z, Stijnen T. Combining multiple outcome measures in a meta-analysis: an application. Statistics in Medicine 2003; 22:1335-1353.
29. Thompson JR, Minelli C, Abrams KR, Tobin MD, Riley RD. Meta-analysis of genetic studies using Mendelian randomisation - a multivariate approach. Statistics in Medicine 2005; 24:2241-2254.
30. Hahn S, Williamson PR, Hutton JL, Garner P, Flynn EV. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Statistics in Medicine 2000; 19:3325-3336.
31. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Applied Statistics 2000; 49:359-370.
32. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 1998; 18:S68-S80.
33. Brodeur GM, Seeger RC, Barrett A et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. Journal of Clinical Oncology 1988; 6:1874-1881.
34. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. Journal of Clinical Epidemiology 2002; 55:86-94.
35. Abrams KR, Lambert PC, Sanso B, Shaw C, Marteau TM. Meta-analysis of heterogeneously reported study results - a Bayesian approach. In Meta-Analysis in Medicine and Health Policy, Stangl D, Berry D (eds). Marcel Dekker: New York, 2000; 29-63.
36. Brown CH, Indurkhya A, Kellam SK. Power calculations for data missing by design: applications to a follow up study of lead exposure and attention. Journal of the American Statistical Association 2000; 95:383-385.
37. Raudenbush SW, Becker BJ, Kalaian H. Modeling multivariate effect sizes. Psychological Bulletin 1988; 103:111-120.
38. Berkey CS, Anderson JJ, Hoaglin DC. Multiple-outcome meta-analysis of clinical trials. Statistics in Medicine 1996; 15:537-557.
39. Hasselblad V. Meta-analysis of multitreatment studies. Medical Decision Making 1998; 18:37-43.
40. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Statistics in Medicine 1995; 14:395-411.
41. Altman DG, Riley RD. An evidence-based approach to prognostic markers. Nature Clinical Practice Oncology 2005; 2:466-472.
42. DuMouchel W. Repeated measures meta-analysis. Bulletin of the International Statistical Institute. Session 51, Tome LVII, Book 1, 285-288.
43. Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Statistics in Medicine 1993; 12:2273-2284.